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Abstract : Cerebral pentose phosphate pathway (PPP)
activity has been linked to NADPH-dependent anabolic
pathways, turnover of neurotransmitters, and protection
from oxidative stress . Research on this potentially im-
portant pathway has been hampered, however, because
measurement of regional cerebral PPP activity in vivo has
not been possible . Our efforts to address this need fo-
cused on the use of a novel isotopically substituted glu-
cose molecule, [1,6- 1'3C2,6,6- 2H2]glucose, in conjunction
with microdialysis techniques, to measure cerebral PPP
activity in vivo, in freely moving rats . Metabolism of [1,6-
13C2 ,6,6- 2H2]glucose through glycolysis produces [3-
"C] lactate and [3-"C,3,3-2 H2] lactate, whereas metabo-
lism through the PPP produces [3- 13C 3,3_ 2H21 lactate
and unlabeled lactate . The ratios of these lactate isoto-
pomers can be quantified using gas chromatography/
mass spectrometry (GC/MS) for calculation of PPP activ-
ity, which is reported as the percentage of glucose me-
tabolized to lactate that passed through the PPP. Follow-
ing addition of [1,6-13C2 ,6,6- 2H2]glucose to the perfu-
sate, labeled lactate was easily detectable in dialysate
using GC/MS. Basal forebrain and intracerebral 9L gli-
oma PPP values (mean ± SD) were 3.5 -} 0.4 (n = 4)
and 6.2 ± 0.9% (n = 4), respectively . Furthermore, PPP
activity could be stimulated in vivo by addition of phen-
azine methosulfate, an artificial electron acceptor for
NADPH, to the perfusion stream . These results show that
the activity of the PPP can now be measured dynamically
and regionally in the brains of conscious animals in vivo .
Key Words: Pentose phosphate pathway-Microdial-
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The main functions of the oxidative branch of the
pentose phosphate pathway (PPP) are to supply ribose
5-phosphate for nucleotide synthesis and to produce
reducing equivalents in the form of NADPH for bio-
synthetic reactions . The NADPH produced by the PPP
also plays an important role in maintaining glutathione
in its reduced state . The parameter P, which is defined
as the percentage of glucose metabolized to lactate that
passes through the PPP, is considered to be relatively
small in the brain (-2-8% of the total glucose con-
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sumed in rats) (Hostetler and Landau, 1967; Hostetler
et al ., 1970 ; Baquer et al ., 1975 ; Gaitonde et al ., 1983) .
However, the fact that P can be stimulated to as much
as 80-fold (Baquer et al ., 1977 ; Hothersall et al ., 1979)
suggests that the PPP has an enormous reserve capacity
and indicates that it may play an important role under
certain physiological or pathological conditions . For
example, the PPP has been suggested to possess a func-
tional significance in various conditions such as the
developing (Baquer et al ., 1977) and aging (Zubairu
et al ., 1983) brain and in gliomas (Coleman and Allen,
1978) . Studies of excised glioma tissue have reported
an increased PPP flux as compared with normal brain
(Loreck et al ., 1987) . In addition, stimulation of PPP
activity by catecholamines was demonstrated in iso-
lated synaptosomes (Appel and Parrot, 1970) and
whole-brain preparations (Baquer et al ., 1977), and a
further link to neurotransmission may occur via the
aldehydes produced by the catalytic action of mono-
amine oxidase, which are reduced to their correspond-
ing alcohols by an NADPH-dependent aldehyde reduc-
tase (Tabakoff et al ., 1974) . Baquer et al . (1975) have
proposed that the PPP also provides the NADPH uti-
lized by the glutathione pathways for cellular protec-
tion from oxidative injury . Oxidative stress can occur
during periods where the production of hydrogen per-
oxide is produced by increased monoamine oxidase
activity (Hothersall et al ., 1982) . Further evidence that
a stimulation in PPP activity by monoamine transmitter
degradation products is mediated by detoxification of
H202 and the reduction of aldehydes to alcohols in
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synaptosomes was provided by Hothersall et al .
(1982) .
These studies indicate that the cerebral PPP may be
of considerable importance in both normal and patho-
logical states . However, at present no method is avail-
able to monitor regional brain PPP activity in vivo .
Attempts to measure PPP activity in rat brain by quan-
tifying differences in glucose utilization in different
brain regions with I I -'4Cj glucose and 16- ' `C ] glucose
have been unsuccessful (Hawkins et al ., 1985 ; Duncan
et al ., 1988) . More recently, Dienel et al . ( 1992) at-
tempted to measure regional PPP activity by quantify-
ing local rates of glucose utilization, determined with
deoxy [ 1-' `C ] glucose and deoxy [ 6-'`'C ]glucose, but
concluded that PPP activity in normal adult rat brain
was too low to be measured in vivo . An alternate novel
approach involves the use of [1,6-"G,6,6-'-H,j-
glucose, which was recently reported useful for mea-
suring PPP activity in cultured cells (Ross et al .,
1994) . In the present report we demonstrate that 11,6-
"G,6,6_ 2H, ]glucose, in combination with intracere-
bral microdialysis techniques, can also be used to ob-
tain dynamic measurements of regional PPP activity




D-[l,6-"C=,6,6- -H,]Glucose was purchased from Omi-
cron Biochemicals (South Bend, IN,_U.S.A .) . Enrichments
of "C and -H atoms on the isotopically substituted glucose
molecule were determined to be 99 and 98°10, respectively,
from high-resolution "C and 'H NMR studies . Bis(trimcthyl-
silyl)trifluoroacetamide was obtained from Alltech Associ-
ates (Deerfield, IL, U.S .A .) . Cell culture medium was ob-
tained from GIBCO/BRL (Grand Island, NY, U.S.A .) . All
other chemicals were from Sigma Chemical Co . (St. Louis,
MO, U.S.A .) .
Cell culture conditions
Rat 9L glioma cells were grown as monolayers in modi-
fied Eagle's minimal essential medium containing 10"/0 fetal
bovine serum, 100 units/ml of penicillin, and 100 p.g/ml of
streptomycin . Cells were cultured in an incubator at 37°C in
an atmosphere containing 95% air and 5% CO, . Glioma
cells were harvested by trypsinization and concentrated in
serum-free medium to yield an intracerebral inoculum dose
of 10' glioma cells/5 pl .
Induction of brain tumors
Male Fischer rats weighing between 150 and 200 g were
used for in vivo brain tumor studies . Rats were anesthetized
by an intraperitoneal injection of a mixture containing keta-
mine (80-100 mg/kg) and xylazine (13 mg/kg) . A small
incision was made -3 mm behind the right eye and 2.5 mm
from inidline . A high-speed drill was used to create a I -nun-
diameter burr hole through the skull . The right forebrain was
inoculated with 10' cells in 5 NI at a depth of 3 mm. The
burr hole was filled with bone wax to minimize the potential
for extracerebral extension of the tumor tissue . The skin was
sutured, and the rats were allowed to recover. Between 18
and 22 days postimplantation, rats with glioma cell implants
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underwent examination by magnetic resonance imaging
(MRI) for assessment of tumor size and location for subse-
quent placement of the microdialysis probe.
MRI
In vivo magnetic resonance experiments were performed
on a Spectroscopy Imaging Systems Corp. (SISCO) imaging
spectrometer system equipped with a 7.0-Tesla, I8 .3-cm ho-
rizontal-bore magnet . Animals were maintained at 37°C us-
ing a circulating water blanket placed under the torso . The
rat's head was positioned inside a 5-cm-diameter birdcage
radiofrequency coil and placed inside the center of the mag-
net. Each MRI session included (a) single-slice gradient-
recalled-echo scanning with 1-mm "saturation cross-hairs"
imprinted on the axial and coronal images to facilitate rapid
positioning of the coil and (b) a T,-weighted (TRITE
- 3,000/60 iris) 20-slice , can through the brain (1 mm slice
thickness, 128 X 128 matrix) for determination of the size
and location of the tumor to guide subsequent implantation
of microdialysis probes .
Construction and implantation of microdialysis
probes
Concentric-style microdialysis probes were similar to
those described by Robinson and Camp ( 1991 ) with the
following modifications. The inlet and outlet tubing con-
sisted of fused silica capillary tubing (inlet, 150 N.m o.d ., 75
pin i .d . : outlet, 170 pin o .d ., 100 pin i.d .) . The regenerated
cellulose hollow dialysis fiber had an effective length of 6
mm and extended from the surface of the dura to 6 mm
ventral . The dialysis fiber had a nominal molecular mass
cut-off of 5,000-6,000 Da, an i .d . of 215 pm, and a wall
thickness of 18 pin (o .d . - 251 pin) .
Male Fischer rats weighing 250-350 g were injected with
0.15 ml of atropine methylnitrate (0 .5 mg/ml) and then anes-
thetized with sodium pentobarbital . A 21-ga stainless steel
guide eannula was placed on the dural surface using standard
stereotactic techniques . The coordinates used (with bregma
horizontal to X) were 0.6 mm anterior to bregma, 3 .6 mm
lateral from the midlinc, and 1 .0 mm from the skull surface .
The guide eannula was then fixed to the skull using jeweler's
screws and cranioplast dental cement. A 26-ga stylet pro-
truded I mm beyond the tip of the eannula to maintain
patency. Animals were allowed to recover for 6-7 days
before probe implantation . One day before a dialysis experi-
ment, the dialysis probe was attached to a liquid swivel,
which in turn was connected to a gas-tight Hamilton syringe
mounted on a syringe pump, and the perfusion solution was
pumped through the probe at 0.3 p.l/min . The dialysis probe
was then lowered into the implanted guide eannula. The
animals were attached to the liquid swivel via a tether con-
nected to a piece of stainless steel tubing mounted to the
clental acrylic cap and placed into test chambers . The perfu-
sion solution, which was filter-sterilized, consisted of 145
inM NaCl, 2.7 mM KCI, 1 .3 mM CaCk, 1 .0 mM MgCl,,
and 0.2 mM ascorbic acid, pH 7.3 . On the day of the experi-
ment, the perfusion solution was replaced with fresh solution
containing 100 mM 11,6-"C-,6 .6- -H,(glucose, and the flow
rate was adjusted to 1 .0 pl/min . After a 60-min equilibration
period, dialysate samples were continuously collected in
polyethylene tubes at 50-min intervals over the experimental
period.
For animals with intracranial 9L tumors, MRI was per-
formed 2 days before microdialysis experiments to determine
the size and location of the tumor within the brain paren-
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chyma. Surgical attachment of guide cannulas for tumor-
bearing rats was carried out as described above, and animals
were allowed to recover for 1-2 days . Probes were typically
implanted l mm posterior to the tumor injection site, which
was essentially the same site as for controls .
Microdialysis equilibration studies
To determine the dynamics and extent of incorporation
of the label from labeled glucose to lactate, microdialysis
experiments were performed on normal rat brains using [I-
"C ]glucose in the perfusion stream . Rats (n = 3 per group)
with implanted dialysis probes were perfused with [1-"C]-
glucose at a concentration of 10, 50, 75, 100, or 150mM, and
samples were collected every 20 min . The [ 1_ 13C] glucose
solutions were added and removed at 20 and 200 min, re-
spectively, following initiation of sample collection . Dialysis
samples were collected for a total of 260 min. Lactate frac-
tional enrichment was calculated using the m/z 219 and 220
ions obtained from gas chromatography /mass spectrometry
(GC/MS) analysis .
GC/MS analysis
All GC/MS measurements were performed as previously
described (Ross et al ., 1994) . In brief, samples were lyophi-
lized to dryness and derivatized by adding 50 p1 of pyridine
and 50 y1 of (trimethylsilyl)trifluoroacetamide and heating
for 15 min at 60°C . The samples were then centrifuged at
12,000 g for 10 min . The supernatant was pipetted off and
placed into a vial, which was then sealed with a Teflon-
coated septum . The trimethylsilyl (TMS) derivative was
chosen over other possible derivatives because of the ease
of derivatization, its characteristic fragment ions, and its gas
chromatographic separation from interfering compounds. An
HP 5890/5971 GC/MS system with arfHP DB-5 fused silica
column (30 m X 0.25 mm X 0.25 urn) with helium as the
carrier gas was used . Dwell time was 20 ms, and electron
multiplier voltage during acquisition was 2,280 V. The col-
umn temperature program was 0.75 min at 55'C followed
by a temperature ramp at 15°C/min to 140°C . The tempera-
ture was then increased to 280'C at 30'C/min and held for
3 min . Selected ion monitoring was performed on the m/z
219, 220, 221, and 222 ions, which correspond predomi-
nately to unlabeled lactate, [3-' 3C]lactate, [3-"C,3-'H]-
lactate, and [3-'3C,3,3-'Hz] lactate, respectively (Ross et al .,
1994) . These ions correspond to the loss of a methyl group
from the TMS derivative of lactic acid . Under these chro-
matographic conditions the lactate peak was well resolved
with no interfering peaks.
In vitro isotopic dilution studies
In the TMS derivative of lactate, each atom contains sev-
eral naturally occurring isotopes . With this silylated deriva-
tive, -20°Io of the mlz 219 ion is found in the M+ l (mlz
220) ion owing to naturally occurring isotopes of carbon
and silicon . When the amount of labeled lactate is low, quan-
tification of the [3-' 3C]lactate in the m. /z 220 ion can be-
come difficult, resulting in an incorrectly calculated PPP
activity . This could potentially become significant for in vivo
microdialysis studies because of the presence of unlabeled
blood glucose and other sources of endogenous unlabeled
lactate precursors . To determine the relative amount of unla-
beled lactate, which would affect the accurate quantification
of labeled lactate and ultimately the calculation of accurate
PPP activities, isotopic dilution studies were undertaken us
ing 9L glioma cultures . For these studies, [1,6- 13C2 ,6,6-
J. Neurochem, Vol. 64, No . 3, 1995
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'H z ]glucose was diluted from 100 to 10% in 10% steps
while maintaining the total concentration of glucose constant
at 5.5 mM in Krebs-Ringer's buffer . Incubations were per-
formed in 24-well culture plates for 30 min, and each con-
centration was replicated using four wells for statistical anal-
ysis .
Calculation of PPP activity
The GC/MS intensities were adjusted for their natural
isotopic composition and resolved into 1 C I ]lactate and
[C6]lactate components originating from the CI and C6
positions of glucose, respectively . ThePPP activity is calcu-
lated using the following equation as previously described
(Ross et al ., 1994) : P = 1 - [C1]lactate/[C6]lactate . A
small adjustment can be made to compensate for recycling
of glucose 6-phosphate through the PPP (Ross et al ., 1994) .
Figure 1 shows the labeling patterns of metabolites of
glycolysis and the PPP when [1,6-' 3C ,6,6-'H,]glucose is
used as precursor . Metabolism of [1,6-"C=,6,6-'H,]glucose
through the glycolytic pathway to lactate results in the forma-
tion of 13-'3C]lactate (In/7 = 220) and [3-13C,-I,3-'Hz]-
lactate (nz/z, = 222), from the C 1 and C6 positions of glu-
cose, respectively . In contrast, metabolism of [1,6-'3C,,6,6-
'H,]glucose through the oxidative pathway of the PPP re-
sults in a loss of label from the C1 position of glucose as
'3COZ due to the decarboxylation of 6-phosphogluconate by
the catalytic action ofphosphogluconate dehydrogenase . La-
beling of sugars in the nonoxidative part of the PPP will
thus appear in the C5 position of ribose 5-phosphate and
xylulose 5-phosphate, the C7 position of sedoheptulose 7-
phosphate, the C4 position of erythrose 4-phosphate, the C3
position of glyceraldehyde 3-phosphate, and the C6 position
of fructose 6-phosphate . Reentry of glyceraldehyde 3-phos-
phate and fructose 6-phosphate derived from the PPP into
glycolysis results in the production of 13- "C,3,3-'H=]lactate
(m/z = 222) and unlabeled lactate (rill-, = 219) . The activ-
ity of the PPP can be calculated as described above using the
lactate isotopomer values obtained from GC/MS analysis .
RESULTS AND DISCUSSION
In vitro isotopic dilution studies
The TMS derivative of unlabeled lactate (m/,-.
= 219) contains a significant isotopic tail that contri-
butes 19 .4, 8 .9, and 1 .2% of its area to the 1n/z = 220,
221, and 222 labeled lactate species, respectively . In
vitro incubation studies were undertaken to determine
the amount of unlabeled lactate at which quantification
of the labeled lactate in the rnlz 220 peak becomes
difficult. Glioma cells were incubated with increasing
dilutions of [1,6-"C,,6,6-'H-]glucose with unlabeled
glucose, and the activity of the PPP was determined .
A relatively constant value of basal PPP activity was
obtained when the proportion of [1,6-13CZ,6,6-'H,]-
glucose in the medium was ~-30°Io (Fig . 2) . Accurate
PPP values were obtained down to 20% fractional en-
richment of glucose, at which point the uncorrected
(m/l- 219)/(m/z 220) ratio was 3.5 . To allow a margin
of safety, it is suggested that the ratio of (m/z 219)/
(mlz 220) should be kept below -3.0 (at 30% labeled
glucose) . A similar pattern was observed at the upper
range of PPP activity during stimulation with 50 pM
PMS. This point is of importance because microdia-
FIG . 1 . The fate of [1,6-' 3C 2 ,6,6- 2H2 1-
glucose through glycolysis and the pentose
phosphate pathway (PPP) . Interconversion
of sugar moieties refers to the nonoxidative
branch of the PPP . G and P indicate the
origin of a metabolite from glycolysis or
PPP . Glc-6P, glucose 6-phosphate ; PG,
phosphogluconate ; Ru5P, ribulose 5-phos-
phate ; Fru6P, fructose 6-phosphate; GIy3P,
glyceraldehyde 3-phosphate ; PEP, phos-
phoenolpyruvate .
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lysis measurements ofin vivo PPP will have significant
contributions of unlabeled lactate from metabolism of
unlabeled glucose in the blood, which would be metab-
olized along with [1,6- "C2,6,6 -ZH2] glucose in the per-
fusion stream . If the (m/z 219)/(m/z 220) ratio of 3-
3 .5 cannot be achieved owing to the presence of high
levels of unlabeled lactate precursors, it may be possi-
ble to obtain useful data by using the n-propyl hep-
tafluorobutyrate derivative of lactate (Tserng et al .,
1984) .
Microdialysis equilibration studies
To determine the dynamics of lactate enrichment
and washout following a change in the amount of la-
beled glucose in the perfusion stream, [I - "C ]glucose
was added to the perfusion stream at 10, 50, 75, or
100 mM, and the percent enrichment in lactate was
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determined over time . Because only half of the lactate
produced from this glucose is labeled, the fractional
enrichment would be approximately doubled if [1,6-
"CZ ,6,6-`H Z]glucose was used . The [1-"C]glucose
was added at 20 min following initiation of experi-
ments and was removed at 200 min . The percent en-
richment of lactate increased for 40 min following ad-
dition of [ 1-' 3C ] glucose and plateaued until [ 1- "C] -
glucose was replaced by unlabeled glucose (Fig. 3) .
Maximal enrichments of -25% were achieved within
40 min after administration of 75, 100, and 150 mM
(data not shown) [1-' 3C]glucose . A similar pattern
was observed with 50 mM [ 1- "C ]glucose with a
slightly lower maximal fractional enrichment of 22% .
With 10 mM [1-"C]glucose in the perfusion solution,
maximal enrichment reached only 11 % . These results
indicate that an equilibration period of at least 40 min
J. Neitrochem_ Vol. 64, No. 3 . 1995
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FIG . 2 . PPP activity in cultured 9L glioma cells with different
mole fractions of [1,6- 13 C2,6,6-Z H2]glucose during a 30-min in-
cubation period . Total glucose concentrations were maintained
at 5 .5 mM for all enrichment conditions . PPP activity was deter-
mined under (A) basal conditions and (B) in the presence of 50
pM PMS . Data are mean ± SD (bars) values (n = 4) .
was required for labeling to reach a plateau . The results
shown in Fig . 3 also indicate that increasing the amount
of labeled glucose in the perfusion stream to >75 mM
will not significantly increase the amount of labeled
lactate . Once the labeled glucose was withdrawn from
the perfusion stream, a similar duration was required
for label washout .
The fractional enrichment of lactate did not increase
when the glucose concentration was increased to >75
mM [1-'3C]glucose . At 50 mM [1-"C]glucose, how-
ever, the fractional enrichment was slightly but sig-
nificantly lower . This suggests that glucose carrier sat-
uration occurs between these two concentrations . As-
FIG . 3. GC/MS measurements of lactate fractional enrichment
in the dialysate collected from rat forebrain versus time following
addition and removal of [1-"C]glucose to the perfusion stream
at 20 and 200 min, respectively. Samples were collected at 20-
min intervals following perfusion with 10, 50, 75, or 100 mM [1-
'aC]glucose in the perfusion solution . Data are mean -!- SD (bars)
values (n = 3) .
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FIG . 4 . Representative coronal T2-weighted (TRITE = 3,000/
60, slice thickness = 0.5 mm) magnetic resonance image of an
intracranial 9L glioma in the forebrain of a rat used for placement
of dialysis probe . The tumor is evident as a large hyperintense
region in the right hemisphere .
suming that glucose transport becomes saturated at
-20 mM (Bachelard et al ., 1973) and that the normal
concentration of unlabeled brain glucose is 5 mM, it
appears that - 15 mM glucose diffused from the perfu-
sion solution through the dialysis probe when 75 mM
[ 1- "C ] glucose was present in the perfusion solution .
This corresponds to -20aIo diffusion of glucose across
the dialysis probe membrane .
Measurements of PPP activity in brain and
in solid tumor
Magnetic resonance images of the brain were ac-
quired to ensure proper placement of dialysis probes
into intracranial 9L gliomas . A representative T--
weighted image of an intracranial 9L glioma is shown
in Fig. 4 . The glioma is clearly delineated in the right
hemisphere as a large hyperintense region . Selective
collection of dialysates from the intracranial gliomas
was easily achieved by preimaging the brains so that
the proper location and depth of the dialysis probe
could be determined for individual tumors .
The PPP activity in brain and glioma was measured
over 50-min intervals using 100 mM [1,6-"C2,6,6-
2H2 ]glucose in the perfusion stream, and the results
are shown in Fig . 5 . Basal activity in normal brain
was 3 .5 ± 0.4% (mean - SD, n = 4), which is in
agreement with studies by Hostetler and Landau
(1967), who reported PPP activity of 3-5% in whole
rat brain extracts following administration of [2-"C]-
glucose . Lower values between 0.5 and 2.5% have
also been reported using other cerebral preparations
(Coleman and Allen, 1978 ; Hothersall et al ., 1979 ;
Bauer and Brand, 1982) .
It has been reported previously that PPP activity is
significantly elevated in tumor tissue . For example,
values of 7.5 ± 1 .5 and 5 .1 ± 1 .2% were obtained in
C6 and 9L glioma cultures, respectively (Kingsley-
Hickman et al ., 1990) . Similarly, in the present study,
basal PPP activity in 9L glioma tissue in vivo was 6.2
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FIG . 5 . PPP activity in the forebrain and 9L glioma of conscious
rats versus time . Samples were collected at 50-min intervals .
Stimulation of the PPP to 18 .7 - 1 .9 and 8.4 ± 1 .1 % was ob-
served for (line A) normal brain (O) and (line B) tumor ( " ),
respectively, following addition of 50 p,M PMS to the perfusion
solution at 250 min . Recovery of PPP activity to basal levels
occurred over time following removal of PMS at 400 min . Data
are mean ± SD (bars) values .
- 0.9% (mean ± SD, n = 4), which is significantly
higher than observed in normal cerebral tissue (Fig.
5) . The higher basal PPP activity of the 9L glioma
compared with normal brain is probably associated
with an elevated NADPH requirement necessary for
the increased nucleic acid, steroid, and lipid biosynthe-
sis of the proliferating neoplasm .
Glucose 6-phosphate dehydrogenase is the sole reg-
ulatory enzyme of the pathway, and the activity is
modulated by the NADPH/NADP + ratio . For this rea-
son compounds that are metabolized via NADPH-con-
suming pathways will cause PPP stimulation, whereas
compounds that block NADPH utilization will inhibit
the pathway (Fabregat et al ., 1985) . Phenazine metho-
sulfate (PMS), an electron acceptor for NADPH, is
known to reduce the NADPH/NADP } ratio (Dickens
and McIlwain, 1938), thus pulling the glucose 6-phos-
phate dehydrogenase equilibrium toward 6-phospho-
gluconate production . Addition of 50 ICM PMS to the
perfusion solution at 250 min after [1,6-"C2,6,6-2H2]-
glucose administration resulted in stimulation of the
pathway to 18.7 ± 1 .9% in brain and to 8.4 ± 1 .1%
in tumor (Fig . 5) . PPP activity returned to basal levels
following removal of PMS from the perfusion solution
at 400 min . The exact reasons for the apparent in-
creased stimulation of brain PPP compared with gli-
oma at dialysate concentrations of 50 pM PMS are
outside the scope of this present study and remain a
topic for further research . Under these experimental
conditions, the lactate (m/z 219)/(m/z 220) ratio of
dialysis samples was 1 .5, which is acceptable for accu-
rate quantification of PPP activity .
Finally, in pilot experiments (data not shown) dialy-
sate samples were collected in l0-min intervals to de-
termine the potential temporal resolution of this
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method . It was found that with 50 mM [l,6-'3C2,6,6-
2H2] glucose in the perfusion stream PPP activity could
be easily monitored over -5 10-min intervals . Further-
more, with 50 mM glucose, the lactate (m/z 219)/
(m/z 220) ratio was 1 .8, suggesting that it should be
feasible to decrease further the concentration of [1,6-
"Cz,6,6- 2H2 ]glucose in the perfusion stream .
In conclusion, the results reported here indicate that
[1,6- 13C2,6,6-2HZ ] glucose can be used to quantify re-
gional PPP activity in the brain of conscious rats when
coupled with microdialysis techniques . This method
allows sampling of discrete brain regions with reason-
able temporal resolution, and it should be practical to
monitor PPP activity under various physiologi-
cal, behavioral, or pathological conditions . This novel
method should facilitate further studies of the role of
the PPP in the CNS .
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